Thiazolidinediones improve insulin sensitivity without hypoglycemic risk by activation of peroxisome proliferator-activated (PPAR)-γ with other nonglycemic effects, including anti-inflammatory and improved lipid profiles via PPAR-α/γ.
Source: wiktionary